Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Adapalene Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Adapalene Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Cream
  • 1.4.3 Gel
  • 1.4.4 Lotion
• 1.5 Market by Application
  • 1.5.1 Global Adapalene Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Compounding Pharmacy
  • 1.5.4 Skin Clinic
  • 1.5.5 Beauty Center
  • 1.5.6 Brick-and-mortar Pharmacy
  • 1.5.7 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Adapalene Market Perspective (2015-2026)
• 2.2 Adapalene Growth Trends by Regions
  • 2.2.1 Adapalene Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Adapalene Historic Market Share by Regions (2015-2020)
  • 2.2.3 Adapalene Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Adapalene Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Adapalene Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Adapalene Players by Market Size
  • 3.1.1 Global Top Adapalene Players by Revenue (2015-2020)
  • 3.1.2 Global Adapalene Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Adapalene Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Adapalene Market Concentration Ratio
  • 3.2.1 Global Adapalene Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Adapalene Revenue in 2019
• 3.3 Adapalene Key Players Head office and Area Served
• 3.4 Key Players Adapalene Product Solution and Service
• 3.5 Date of Enter into Adapalene Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Adapalene Historic Market Size by Type (2015-2020)
• 4.2 Global Adapalene Forecasted Market Size by Type (2021-2026)

5 Adapalene Breakdown Data by Application (2015-2026)

• 5.1 Global Adapalene Market Size by Application (2015-2020)
• 5.2 Global Adapalene Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Adapalene Market Size (2015-2020)
• 6.2 Adapalene Key Players in North America (2019-2020)
• 6.3 North America Adapalene Market Size by Type (2015-2020)
• 6.4 North America Adapalene Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Adapalene Market Size (2015-2020)
• 7.2 Adapalene Key Players in Europe (2019-2020)
• 7.3 Europe Adapalene Market Size by Type (2015-2020)
• 7.4 Europe Adapalene Market Size by Application (2015-2020)

8 China

• 8.1 China Adapalene Market Size (2015-2020)
• 8.2 Adapalene Key Players in China (2019-2020)
• 8.3 China Adapalene Market Size by Type (2015-2020)
• 8.4 China Adapalene Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Adapalene Market Size (2015-2020)
• 9.2 Adapalene Key Players in Japan (2019-2020)
• 9.3 Japan Adapalene Market Size by Type (2015-2020)
• 9.4 Japan Adapalene Market Size by Application (2015-2020)

10 Key Players Profiles

• 10.1 Galderma
  • 10.1.1 Galderma Company Details
  • 10.1.2 Galderma Business Overview and Its Total Revenue
  • 10.1.3 Galderma Adapalene Introduction
  • 10.1.4 Galderma Revenue in Adapalene Business (2015-2020))
  • 10.1.5 Galderma Recent Development
• 10.2 Glenmark Pharmaceuticals
  • 10.2.1 Glenmark Pharmaceuticals Company Details
  • 10.2.2 Glenmark Pharmaceuticals Business Overview and Its Total Revenue
  • 10.2.3 Glenmark Pharmaceuticals Adapalene Introduction
  • 10.2.4 Glenmark Pharmaceuticals Revenue in Adapalene Business (2015-2020)
  • 10.2.5 Glenmark Pharmaceuticals Recent Development
• 10.3 Fougera Pharmaceuticals
  • 10.3.1 Fougera Pharmaceuticals Company Details
  • 10.3.2 Fougera Pharmaceuticals Business Overview and Its Total Revenue
  • 10.3.3 Fougera Pharmaceuticals Adapalene Introduction
  • 10.3.4 Fougera Pharmaceuticals Revenue in Adapalene Business (2015-2020)
  • 10.3.5 Fougera Pharmaceuticals Recent Development
• 10.4 A-S Medication Solutions
  • 10.4.1 A-S Medication Solutions Company Details
  • 10.4.2 A-S Medication Solutions Business Overview and Its Total Revenue
  • 10.4.3 A-S Medication Solutions Adapalene Introduction
  • 10.4.4 A-S Medication Solutions Revenue in Adapalene Business (2015-2020)
  • 10.4.5 A-S Medication Solutions Recent Development
• 10.5 Taro Pharmaceuticals
  • 10.5.1 Taro Pharmaceuticals Company Details
  • 10.5.2 Taro Pharmaceuticals Business Overview and Its Total Revenue
  • 10.5.3 Taro Pharmaceuticals Adapalene Introduction
  • 10.5.4 Taro Pharmaceuticals Revenue in Adapalene Business (2015-2020)
  • 10.5.5 Taro Pharmaceuticals Recent Development
• 10.6 Sandoz Inc.
  • 10.6.1 Sandoz Inc. Company Details
  • 10.6.2 Sandoz Inc. Business Overview and Its Total Revenue
  • 10.6.3 Sandoz Inc. Adapalene Introduction
  • 10.6.4 Sandoz Inc. Revenue in Adapalene Business (2015-2020)
  • 10.6.5 Sandoz Inc. Recent Development
• 10.7 Prasco Laboratories
  • 10.7.1 Prasco Laboratories Company Details
  • 10.7.2 Prasco Laboratories Business Overview and Its Total Revenue
  • 10.7.3 Prasco Laboratories Adapalene Introduction
  • 10.7.4 Prasco Laboratories Revenue in Adapalene Business (2015-2020)
  • 10.7.5 Prasco Laboratories Recent Development
• 10.8 Actavis Pharma Company
  • 10.8.1 Actavis Pharma Company Company Details
  • 10.8.2 Actavis Pharma Company Business Overview and Its Total Revenue
  • 10.8.3 Actavis Pharma Company Adapalene Introduction
  • 10.8.4 Actavis Pharma Company Revenue in Adapalene Business (2015-2020)
  • 10.8.5 Actavis Pharma Company Recent Development
• 10.9 Perrigo
  • 10.9.1 Perrigo Company Details
  • 10.9.2 Perrigo Business Overview and Its Total Revenue
  • 10.9.3 Perrigo Adapalene Introduction
  • 10.9.4 Perrigo Revenue in Adapalene Business (2015-2020)
  • 10.9.5 Perrigo Recent Development
• 10.10 Physicians Total Care
  • 10.10.1 Physicians Total Care Company Details
  • 10.10.2 Physicians Total Care Business Overview and Its Total Revenue
  • 10.10.3 Physicians Total Care Adapalene Introduction
  • 10.10.4 Physicians Total Care Revenue in Adapalene Business (2015-2020)
  • 10.10.5 Physicians Total Care Recent Development
• 10.11 DPT Laboratories
  • 10.11.1 DPT Laboratories Company Details
  • 10.11.2 DPT Laboratories Business Overview and Its Total Revenue
  • 10.11.3 DPT Laboratories Adapalene Introduction
  • 10.11.4 DPT Laboratories Revenue in Adapalene Business (2015-2020)
  • 10.11.5 DPT Laboratories Recent Development
• 10.12 Tianjin Jinyao Pharmaceutical
  • 10.12.1 Tianjin Jinyao Pharmaceutical Company Details
  • 10.12.2 Tianjin Jinyao Pharmaceutical Business Overview and Its Total Revenue
  • 10.12.3 Tianjin Jinyao Pharmaceutical Adapalene Introduction
  • 10.12.4 Tianjin Jinyao Pharmaceutical Revenue in Adapalene Business (2015-2020)
  • 10.12.5 Tianjin Jinyao Pharmaceutical Recent Development
• 10.13 Heilongjiang fuhe Pharmaceutical Group
  • 10.13.1 Heilongjiang fuhe Pharmaceutical Group Company Details
  • 10.13.2 Heilongjiang fuhe Pharmaceutical Group Business Overview and Its Total Revenue
  • 10.13.3 Heilongjiang fuhe Pharmaceutical Group Adapalene Introduction
  • 10.13.4 Heilongjiang fuhe Pharmaceutical Group Revenue in Adapalene Business (2015-2020)
  • 10.13.5 Heilongjiang fuhe Pharmaceutical Group Recent Development
• 10.14 Sichuan Mingxin Pharmaceutical
  • 10.14.1 Sichuan Mingxin Pharmaceutical Company Details
  • 10.14.2 Sichuan Mingxin Pharmaceutical Business Overview and Its Total Revenue
  • 10.14.3 Sichuan Mingxin Pharmaceutical Adapalene Introduction
  • 10.14.4 Sichuan Mingxin Pharmaceutical Revenue in Adapalene Business (2015-2020)
  • 10.14.5 Sichuan Mingxin Pharmaceutical Recent Development
• 10.15 Hainan Quanxing Pharmaceutical
  • 10.15.1 Hainan Quanxing Pharmaceutical Company Details
  • 10.15.2 Hainan Quanxing Pharmaceutical Business Overview and Its Total Revenue
  • 10.15.3 Hainan Quanxing Pharmaceutical Adapalene Introduction
  • 10.15.4 Hainan Quanxing Pharmaceutical Revenue in Adapalene Business (2015-2020)
  • 10.15.5 Hainan Quanxing Pharmaceutical Recent Development
• 10.16 Jiangsu Zhongdan Pharmaceutical
  • 10.16.1 Jiangsu Zhongdan Pharmaceutical Company Details
  • 10.16.2 Jiangsu Zhongdan Pharmaceutical Business Overview and Its Total Revenue
  • 10.16.3 Jiangsu Zhongdan Pharmaceutical Adapalene Introduction
  • 10.16.4 Jiangsu Zhongdan Pharmaceutical Revenue in Adapalene Business (2015-2020)
  • 10.16.5 Jiangsu Zhongdan Pharmaceutical Recent Development
• 10.17 Jiangsu Fubang Pharmaceutical
  • 10.17.1 Jiangsu Fubang Pharmaceutical Company Details
  • 10.17.2 Jiangsu Fubang Pharmaceutical Business Overview and Its Total Revenue
  • 10.17.3 Jiangsu Fubang Pharmaceutical Adapalene Introduction
  • 10.17.4 Jiangsu Fubang Pharmaceutical Revenue in Adapalene Business (2015-2020)
  • 10.17.5 Jiangsu Fubang Pharmaceutical Recent Development

11 Analyst's Viewpoints/Conclusions

12 Appendix

• 12.1 Research Methodology
  • 12.1.1 Methodology/Research Approach
  • 12.1.2 Data Source
• 12.2 Disclaimer

This report focuses on the global Adapalene status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adapalene development in North America, Europe, China and Japan.

The key players covered in this study
Galderma
Glenmark Pharmaceuticals
Fougera Pharmaceuticals
A-S Medication Solutions
Taro Pharmaceuticals
Sandoz Inc.
Prasco Laboratories
Actavis Pharma Company
Perrigo
Physicians Total Care
DPT Laboratories
Tianjin Jinyao Pharmaceutical
Heilongjiang fuhe Pharmaceutical Group
Sichuan Mingxin Pharmaceutical
Hainan Quanxing Pharmaceutical
Jiangsu Zhongdan Pharmaceutical
Jiangsu Fubang Pharmaceutical

Market segment by Type, the product can be split into
Cream
Gel
Lotion
Market segment by Application, split into
Hospital
Compounding Pharmacy
Skin Clinic
Beauty Center
Brick-and-mortar Pharmacy
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan

The study objectives of this report are:
To analyze global Adapalene status, future forecast, growth opportunity, key market and key players.
To present the Adapalene development in North America, Europe, China and Japan.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adapalene are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.